Alex Villiger

Alex Villiger currently serves as Chief Financial Officer at Celonic Group, a position held since May 2024. Previously, Alex held the role of Vice President Finance at Anjarium Biosciences from April 2023 to April 2024 and briefly served as Head Finance ad interim at Celonic Group in 2022. Prior to that, Alex was Vice President Finance at Polpharma Biologics from September 2020 to April 2022. A long tenure at Novartis spanned from May 2002 to August 2020, encompassing various leadership roles including Global Head Finance Biopharmaceutical Process & Drug Development. Alex's career began at PricewaterhouseCoopers, where senior managerial responsibilities were undertaken in Assurance and Advisory Services. Alex holds a degree from the University of St.Gallen.